systematic_review
2008
Trametes versicolor mushroom immune therapy in breast cancer
Standish LJ, Wenner CA, Sweet ES
Published in Journal of the Society for Integrative Oncology
Methodology
Review of preclinical and clinical evidence for Trametes versicolor and PSK as immune therapy in breast cancer
Key Findings
PSK enhances natural killer and T cell activity in laboratory studies and has survival data from Japanese adjuvant trials
Conclusions
Trametes versicolor is a plausible immune adjuvant in breast cancer but Western clinical data are lacking
Limitations
Narrative review; reliance on older non-Western trials
Supplements Studied
Turkey Tail
Mushroom
PSK enhances natural killer and T cell activity in laboratory studies and has survival data from Japanese adjuvant trials
Related Health Concerns
Study Details
Year:2008
Quality Score:4/10
Access Study
This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.